FindTrial
Sign In

Study for accurate diagnosis and treatment of Parkinson's disease by using the combination of TMS-EEG

Study for accurate diagnosis and treatment of Parkinson's disease by using the combination of TMS-EEG

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019216
Enrollment
Unknown
Registered
2018-10-31
Start date
2017-09-30
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Bradykinesia Group:Sick side, SAM region, 10Hz rTMS
Tremor Group:Sick side, M1 region, 1Hz rTMS
Health control:N/A

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Men and women aged 50 to 80 years; 2. Clinical diagnosis of Parkinson's disease by neurologist; 3. Must comprehend Chinese well to ensure adequate comprehension of the EEG and TMS instructions, and of clinical scales; 4. Long-term regular use of anti-Parkinson drugs with poor efficacy.

Exclusion criteria

Exclusion criteria: 1. Any unstable medical condition; 2. Any current or history of neurological disorders, such as stroke, seizure, tumor, hemorrhage, multiple sclerosis, etc.; 3. Currently pregnant or breastfeeding; 4. Under went the treatment of rTMS within past half year; 5. Accepted implant metal.

Design outcomes

Primary

MeasureTime frame
Neurological scale;—

Countries

China

Contacts

Public ContactGuo Yi

Shenzhen People's Hospital

xuanyi_guo@163.com+86 13902978692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026